Is Ipamorelin Legal in Australia?
A neutral look at ipamorelin's regulatory status in Australia: TGA and Poisons Standard framework, WADA listing, and what research-use-only means.
Is ipamorelin legal in Australia?
Ipamorelin is not an approved therapeutic good in Australia. It does not appear on the Australian Register of Therapeutic Goods (ARTG), so there is no registered ipamorelin medicine and no TGA marketing approval for human or animal use. In the Australian retail setting it is supplied strictly as a research-use-only laboratory compound, not for human or animal consumption.
That short answer needs context, because "legal" depends entirely on the purpose. The sections below outline how Australia's Therapeutic Goods Administration (TGA) and the Poisons Standard frame growth hormone secretagogues such as ipamorelin, what the research-use-only label means, and where anti-doping rules sit. None of this is guidance to use the compound. It is regulatory background only.
What ipamorelin is
Ipamorelin is a synthetic pentapeptide, meaning a short chain of five amino acids made in a laboratory. In published research it is described as a selective growth hormone secretagogue and an agonist of the growth hormone secretagogue receptor (GHS-R), the same receptor targeted by the natural hormone ghrelin. For that reason it is often grouped with ghrelin mimetics and other growth-hormone-releasing peptides.
In laboratory models, ipamorelin has been studied for its ability to stimulate the release of growth hormone from the pituitary. Some published studies report that it did so with relatively little effect on cortisol and prolactin compared with certain other secretagogues. These are observations from scientific literature in research settings and are reported here as published findings, not as any claim about outcomes in people.
The TGA and the ARTG
In Australia, therapeutic goods that are imported, supplied, or manufactured for human therapeutic use must generally be entered on the ARTG, which is maintained by the TGA. A product on the ARTG has been assessed for quality, safety, and its intended use.
Ipamorelin is not entered on the ARTG as a registered medicine. It is also not listed in the Permissible Ingredients Determination that governs lower-risk listed medicines. In practice this means there is no finished ipamorelin product that has received TGA approval for sale as a medicine. For a broader explanation of how peptides sit within this framework, see the overview linked below.
The Poisons Standard and scheduling
Separate from ARTG registration, the Poisons Standard (the SUSMP) classifies substances into schedules that determine how they may be accessed. The TGA has described agonists of the ghrelin receptor, known collectively as growth hormone secretagogues, as a class that sits within Schedule 4 of the Poisons Standard.
Schedule 4 is the Prescription Only Medicine category. As a general principle, a Schedule 4 substance intended for human therapeutic use is one that a consumer would ordinarily access only on the authority of a suitably qualified health practitioner. Because ipamorelin is a growth hormone secretagogue, it is captured by that class framing when the intended purpose is human therapeutic use.
This article states the position conservatively. Scheduling decisions and class entries can change over time, and the authoritative source is always the current Poisons Standard and the TGA directly. The key point is that nothing here describes a pathway to personal use.
What research use only means
When an Australian supplier describes a peptide as research-use-only, it means the compound is offered as a laboratory reference material for in-vitro or scientific study, not as a product for human or animal use. It is not food, not a supplement, and not a medicine.
A research-use-only compound is typically labelled to reflect that status. The label signals that the material has not been assessed or approved for therapeutic use and should be handled only in an appropriate research context by people equipped to do so.
- Supplied as a laboratory research chemical, not a medicine or supplement.
- Not intended, labelled, or approved for human or animal consumption.
- Not assessed by the TGA for safety or efficacy in people.
- Handled only within a legitimate research setting.
Ipamorelin and anti-doping rules
Ipamorelin is addressed by the World Anti-Doping Agency (WADA). Growth hormone secretagogues, releasing peptides, and ghrelin mimetics are covered under the peptide hormones, growth factors, related substances and mimetics category (class S2) of the WADA Prohibited List, and ipamorelin is listed within that group. Substances in this class are prohibited at all times, both in and out of competition.
In Australia, Sport Integrity Australia reflects the WADA list for athletes bound by anti-doping rules. Its public substance information indicates that ipamorelin is prohibited at all times. Anyone subject to those rules should check the current WADA Prohibited List and Sport Integrity Australia directly, as the lists are updated periodically.
How ipamorelin compares within its class
Ipamorelin is one of several compounds often grouped under the growth-hormone-secretagogue or releasing-peptide heading. These different molecules act through related but distinct mechanisms, which is part of why they are studied separately in the research literature.
For neutral, educational comparisons of ipamorelin and related research peptides, the overviews below set out how the molecules differ in structure and reported mechanism, again without any usage guidance.
Ipamorelin compound overview CJC-1295 vs ipamorelin explained
The practical bottom line
Putting the pieces together: ipamorelin has no ARTG registration and no TGA approval as a medicine, it is captured by the Schedule 4 growth-hormone-secretagogue class framing when the intended use is human therapeutic use, and it is prohibited at all times under anti-doping rules. Where it is sold in Australia, it is offered only as a research-use-only laboratory compound.
Regulatory settings can change, and this article is general information rather than legal or medical advice. For the current position, the TGA, the Poisons Standard, and Sport Integrity Australia are the authoritative sources.
Frequently asked questions
Is ipamorelin a banned substance?
Ipamorelin is listed by WADA within the peptide hormones and growth factors category (class S2) as a growth hormone secretagogue, and substances in that class are prohibited at all times in sport. It is not an approved medicine on the ARTG in Australia.
Do you need a prescription for ipamorelin in Australia?
Growth hormone secretagogues such as ipamorelin are framed within Schedule 4 (Prescription Only) of the Poisons Standard when intended for human therapeutic use. There is no registered ipamorelin medicine on the ARTG. Where it is sold, it is supplied as a research-use-only compound, not for human use.
Is ipamorelin on the WADA list?
Yes. Ipamorelin is covered under the WADA Prohibited List within the class of peptide hormones, growth factors and mimetics (S2) as a growth hormone secretagogue, prohibited both in and out of competition. Always check the current list, which is updated periodically.
What does research use only mean?
It means the compound is supplied as a laboratory reference material for scientific study, not as a food, supplement, or medicine. It is not intended, labelled, or approved for human or animal consumption and is handled only in a research setting.
Is ipamorelin the same as HGH?
No. HGH (human growth hormone) is a hormone, while ipamorelin is a synthetic pentapeptide described in research as a growth hormone secretagogue that acts on the ghrelin receptor. They are different molecules studied under different regulatory headings.
Is ipamorelin TGA-approved?
No. Ipamorelin is not entered on the Australian Register of Therapeutic Goods and has no TGA marketing approval as a medicine for human or animal use.
Where can I check the current legal status?
The authoritative Australian sources are the TGA and the ARTG database, the current Poisons Standard (SUSMP), and Sport Integrity Australia for anti-doping status. These are updated over time, so they should be checked directly.
This article is general information for research buyers. All Pepology products are supplied strictly for laboratory research use only and are not for human or animal use. Every batch is independently tested by Novagen Laboratories and verifiable on a public register.